Fibrinil MF 500 mg/250 mg Tablet
Images are for reference. Actual packaging may vary.
Tranexamic Acid (500mg) + Mefenamic Acid (250mg)
Strip of 10 tablets • Tablet
A valid prescription is required for this medicine.
Haven’t found an alternative? A health advisor can help you understand what to do next.
We haven't found a cheaper matching alternative in our catalogue right now. Our health advisors can help you explore other options.
Active composition
+1 more active ingredient
Mefenamic acid inhibits cyclooxygenase (COX) enzymes, leading to decreased synthesis of prostaglandins, which mediate pain and inflammation.
Tranexamic Acid inhibits plasminogen activation, preventing fibrinolysis and stabilizing blood clots.
Medical applications
Fibrinil MF 500 mg/250 mg Tablet is a combination medication containing Tranexamic Acid 500 mg and Mefenamic Acid 250 mg, primarily used to manage excessive bleeding and pain associated with menstrual disorders. Tranexamic Acid is an antifibrinolytic agent that works by inhibiting the breakdown of fibrin clots, thereby reducing bleeding. Mefenamic Acid is a nonsteroidal anti-inflammatory drug (NSAID) that provides effective relief from pain and inflammation by blocking the production of prostaglandins, which are responsible for pain and swelling.
This combination is particularly beneficial for women experiencing heavy menstrual bleeding (menorrhagia) accompanied by dysmenorrhea (painful menstruation). Fibrinil MF helps to control bleeding while simultaneously alleviating pain, improving overall comfort during menstruation. It is typically prescribed for short-term use under medical supervision. Patients should follow the prescribed dosage and consult their healthcare provider if they have a history of bleeding disorders, kidney or liver impairment, or allergies to NSAIDs.
Common side effects may include gastrointestinal discomfort, nausea, or dizziness. Avoid use during pregnancy and breastfeeding unless directed by a physician. Fibrinil MF 500 mg/250 mg Tablet offers a dual-action approach to effectively manage menstrual bleeding and pain.
Dosage information not available. Please consult your doctor or pharmacist.
Important precautions
Side-effect information is not available for this medicine. Please consult your doctor or pharmacist.
Fibrinil MF 500 mg/250 mg Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
High Risk
Fibrinil MF 500 mg/250 mg Tablet is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.
Medical Advice
Fibrinil MF 500 mg/250 mg Tablet should be used with caution in patients with kidney disease. Dose adjustment of Fibrinil MF 500 mg/250 mg Tablet may be needed. Please consult your doctor. Use of Fibrinil MF 500 mg/250 mg Tablet is not recommended in patients with severe kidney disease.
Exercise Caution
Fibrinil MF 500 mg/250 mg Tablet may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Consult Doctor
Fibrinil MF 500 mg/250 mg Tablet is probably safe to use in patients with liver disease. Limited data available suggests that dose adjustment of Fibrinil MF 500 mg/250 mg Tablet may not be needed in these patients. Please consult your doctor.
Regular Checkup
0 reviews for Fibrinil MF 500 mg/250 mg Tablet





